Learn
This week in psychedelic business news: Enveric Biosciences uses AI to identify viable psychedelic drug candidates; Novamind launches end-of-life palliative...
But the 23-year-old actor and musician doesn't specify which psychedelics he uses to explore "mystical states of consciousness."...
"We believe in the promise of the resurgence of psychedelic medicine and are proud to be collaborating with Lobe Sciences...
And it sounds like we'll hear more about his psychedelic experiences on ayahuasca in his upcoming memoir, simply titled "Will."...
This week in psychedelic business news: more evidence supporting ketamine for depression; a new use for MDMA; Lobe Sciences makes...
On the flip side, 37% of Oregon adults surveyed said they did not know what psilocybin was....
The Tesla and SpaceX founder, estimated to be worth nearly $200 billion, has previously hinted at using DMT....
The psychedelic bioscience company's top advisor tells Psychedelic Spotlight that psilocybin "affects at least the 5h2C receptor, which is dedicated...
Organizers of the largest psychedelic business event ever promise it's not just a conference, but an experience....
“Women’s desire issues have not been adequately addressed to date, and we believe this treatment incorporating MDMA and psychotherapy has...